海南医学
海南醫學
해남의학
HAINAN MEDICAL JOURNAL
2014年
10期
1454-1456
,共3页
彭程%阮妮%罗有钰%陈东%贾传锋%陈晓锋
彭程%阮妮%囉有鈺%陳東%賈傳鋒%陳曉鋒
팽정%원니%라유옥%진동%가전봉%진효봉
晚期癌痛%居家治疗%自控镇痛%吗啡
晚期癌痛%居傢治療%自控鎮痛%嗎啡
만기암통%거가치료%자공진통%마배
Advanced cancer pain%Home treatment%Patient-controlled analgesia%Morphine
目的:探讨居家晚期癌痛患者采用自控静脉镇痛(PCIA)治疗的可行性和有效性。方法32例Ⅳ期中重度癌性疼痛患者采用吗啡(初始给药剂量根据当时日口服吗啡总量1/3加上日肌注吗啡总量的2/3的2倍作为24 h泵注的连续背景输注剂量)+氟哌利多5 mg+胃复安40 mg用0.9%生理盐水配成100 ml,视患者镇痛效果调节药物浓度,病情需要可应用辅助药,如抗焦虑药/镇静催眠药、激素等。结果患者在PCIA镇痛期间疼痛明显缓解,治疗早期40.6%(13/32)的患者达到完全缓解,93.25%(30/32)的患者癌痛达到中度以上缓解,只有6.2%(2/32)的患者未达到满意效果。随着时间的延长,吗啡剂量的增大,平均初始剂量为(69.5±20.7) mg/d,治疗终点的剂量为(256.5±75.6) mg/d,平均治疗时间为(48.3±13.5) d,生活质量均有一定程度的改善,不良反应轻。结论居家晚期疼痛患者采用自控静脉镇痛治疗具有可行性,且疗效较好。
目的:探討居傢晚期癌痛患者採用自控靜脈鎮痛(PCIA)治療的可行性和有效性。方法32例Ⅳ期中重度癌性疼痛患者採用嗎啡(初始給藥劑量根據噹時日口服嗎啡總量1/3加上日肌註嗎啡總量的2/3的2倍作為24 h泵註的連續揹景輸註劑量)+氟哌利多5 mg+胃複安40 mg用0.9%生理鹽水配成100 ml,視患者鎮痛效果調節藥物濃度,病情需要可應用輔助藥,如抗焦慮藥/鎮靜催眠藥、激素等。結果患者在PCIA鎮痛期間疼痛明顯緩解,治療早期40.6%(13/32)的患者達到完全緩解,93.25%(30/32)的患者癌痛達到中度以上緩解,隻有6.2%(2/32)的患者未達到滿意效果。隨著時間的延長,嗎啡劑量的增大,平均初始劑量為(69.5±20.7) mg/d,治療終點的劑量為(256.5±75.6) mg/d,平均治療時間為(48.3±13.5) d,生活質量均有一定程度的改善,不良反應輕。結論居傢晚期疼痛患者採用自控靜脈鎮痛治療具有可行性,且療效較好。
목적:탐토거가만기암통환자채용자공정맥진통(PCIA)치료적가행성화유효성。방법32례Ⅳ기중중도암성동통환자채용마배(초시급약제량근거당시일구복마배총량1/3가상일기주마배총량적2/3적2배작위24 h빙주적련속배경수주제량)+불고리다5 mg+위복안40 mg용0.9%생리염수배성100 ml,시환자진통효과조절약물농도,병정수요가응용보조약,여항초필약/진정최면약、격소등。결과환자재PCIA진통기간동통명현완해,치료조기40.6%(13/32)적환자체도완전완해,93.25%(30/32)적환자암통체도중도이상완해,지유6.2%(2/32)적환자미체도만의효과。수착시간적연장,마배제량적증대,평균초시제량위(69.5±20.7) mg/d,치료종점적제량위(256.5±75.6) mg/d,평균치료시간위(48.3±13.5) d,생활질량균유일정정도적개선,불량반응경。결론거가만기동통환자채용자공정맥진통치료구유가행성,차료효교호。
Objective To investigate the effects of patient-controlled intravenous analgesia treatment in pa-tients with advanced cancer. Methods 32 patients with moderate to severe periodⅣcancer pain were treated with morphine (initial dose of 24 h continuous background infusion was based on a summation of 1/3 of the 24h oral amount plus 2 times of 2/3 of intramuscular injection amount of morphine)+5 mg droperidol+40 mg metoclopramide paired with 100ml 0.9%saline. The drug concentration was adjusted according to the analgesic effects in patients. Ad-juvant drugs, such as anxiolytics, sedative hypnotics and hormones, were applied according to condition of patients. Results The pain was relieved in patients with PCIA, achieved complete remission in 40.6%(13/32) patients with early treatment, and achieved moderate remission in 93.25%(30/32) patients with cancer pain. Only 6.2%(2/32) pa-tients did not achieve satisfactory effect. With the extension of time, increasing doses of morphine, mean initial dose was (69.5±20.7) mg/d, the dose was (256.5±75.6) mg/d at the end of the treatment, and the average treatment time was (48.3±3.5) d. The quality of life was improved and adverse reactions were light. Conclusion Patient-controlled intra-venous analgesia is feasibility and effectiveness to treat advanced pain.